Fate Therapeutics, Inc.FATENASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank64
3Y CAGR-23.3%
5Y CAGR-12.5%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-23.3%/yr
vs +34.9%/yr prior
5Y CAGR
-12.5%/yr
Recent deceleration
Acceleration
-58.2pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $318.94M | -27.6% |
| 2024 | $440.69M | -12.9% |
| 2023 | $506.22M | -28.3% |
| 2022 | $705.56M | -23.4% |
| 2021 | $921.46M | +48.0% |
| 2020 | $622.46M | +105.9% |
| 2019 | $302.27M | +41.9% |
| 2018 | $213.03M | +102.3% |
| 2017 | $105.29M | +10.8% |
| 2016 | $95.05M | - |